Biggest Investing Moment...
Man Who Called Tesla & Bitcoin: "Nobody is Paying Attention to This"
Click here to see what you are missing

ABOS Insider Trading (Acumen Pharmaceuticals)

Insider Ownership Percentage: N/A
Insider Buying (Last 12 Months): $5,560,000.00
Insider Selling (Last 12 Months): $0.00

Acumen Pharmaceuticals Insider Trading History Chart

This chart shows the insider buying and selling history at Acumen Pharmaceuticals by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Acumen Pharmaceuticals Share Price & Price History

Current Price: $16.14
Price Change: Price Increase of +0.02 (0.12%)
As of 09/24/2021 01:00 AM ET

This chart shows the closing price history over time for ABOS up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
A Morning Routine to Double Your Money in 13 Minutes?
Wake up. Get coffee. Turn on your computer… In 13 minutes... you could be 98% richer… Go play golf... or tennis... or whatever you like.

It's easy… if you follow a few simple instructions.
Click Here to Learn the Secret >>
pixel

Acumen Pharmaceuticals Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
7/6/2021John A. Stalfort, IIIDirectorBuy35,000$16.00$560,000.00View SEC Filing Icon  
7/6/2021Paul B. ManningMajor ShareholderBuy312,500$16.00$5,000,000.00View SEC Filing Icon  
See Full Table
Insider Buying at Acumen Pharmaceuticals?
Sign-up to receive InsiderTrades.com's daily insider buying and selling report for Acumen Pharmaceuticals and related companies.

SEC Filings (Institutional Ownership Changes) for Acumen Pharmaceuticals (NASDAQ:ABOS)

Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in the development of therapeutics for the treatment of Alzheimer's and other neurodegenerative diseases. The company focuses on advancing a targeted immunotherapy drug candidate ACU193, which is in Phase I clinical-stage to target soluble amyloid-beta oligomers. Acumen Pharmaceuticals, Inc. was incorporated in 1996 and is based in Charlottesville, Virginia.
Read More on Acumen Pharmaceuticals

Today's Range

Now: $16.14
Low: $15.29
High: $16.50

50 Day Range

MA: $16.26
Low: $14.50
High: $19.11

52 Week Range

Now: $16.14
Low: $13.95
High: $26.98

Volume

227,626 shs

Average Volume

314,750 shs

Market Capitalization

$653.19 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of Acumen Pharmaceuticals?

Acumen Pharmaceuticals' top insider shareholders include:
  1. John A Stalfort III (Director)
  2. Marc Benioff (CEO)
  3. Nathan B Fountain (Director)
  4. Paul B Manning (Director)
  5. Paul B Manning (Major Shareholder)
  6. Sands Capital Global Venture F (Major Shareholder)
A Morning Routine to Double Your Money in 13 Minutes?
Wake up. Get coffee. Turn on your computer… In 13 minutes... you could be 98% richer… Go play golf... or tennis... or whatever you like.

It's easy… if you follow a few simple instructions.
Click Here to Learn the Secret >>
pixel